Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus Complementary Index kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Enhancing KCC2 function reduces interictal activity and prevents seizures in temporal lobe epilepsy.

Title: Enhancing KCC2 function reduces interictal activity and prevents seizures in temporal lobe epilepsy.
Authors: Donneger, Florian; Zanin, Adrien; Besson, Jeremy; Roussel, Delphine; Kadiri, Yoness; Pagan, Carla; Sinha, Manisha; David, Nicolas; Russeau, Marion; Bielle, Franck; Devaux, Bertrand; Mathon, Bertrand; Navarro, Vincent; Chassoux, Francine; Poncer, Jean Christophe
Source: Proceedings of the National Academy of Sciences of the United States of America; 3/10/2026, Vol. 123 Issue 10, p1-11, 38p
Subject Terms: TEMPORAL lobe epilepsy; SEIZURES (Medicine); PHENOTHIAZINE; SMALL molecules; GABAERGIC neurons; ION transport (Biology); CHLORIDE ions
Abstract: The neuronal K/Cl cotransporter KCC2 regulates the transmembrane chloride gradient, which controls the efficacy of GABAergic signaling. In mesial temporal lobe epilepsy (mTLE) and other neurological disorders, reduced KCC2 expression or function can result in depolarizing GABA signaling, which is thought to contribute to pathological activity and seizures. Therefore, restoring chloride homeostasis represents a promising therapeutic strategy. We investigated the mechanisms and antiseizure effects of two small molecules, prochlorperazine (PCPZ) and CLP-257, that have been identified as potential KCC2 enhancers. We found that both compounds enhance KCC2 function and clustering in cortical neurons while reducing its membrane diffusion, without altering canonical regulatory phosphorylation. CLP-257 also selectively increased extrasynaptic, but not synaptic, GABAA receptor-mediated currents. Using in vitro recordings from resected brain tissue of patients with drug-resistant mTLE and in vivo recordings from a mouse model, we show that PCPZ and CLP-257 (or its prodrug CLP-290) effectively suppressed spontaneous epileptiform activity in both models. These findings reveal that PCPZ and CLP-257 act as genuine KCC2 enhancers and provide experimental evidence of the therapeutic potential of such compounds for treating drug-resistant mTLE. [ABSTRACT FROM AUTHOR]
: Copyright of Proceedings of the National Academy of Sciences of the United States of America is the property of National Academy of Sciences and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index